ENTITY

Amicus Therapeutics (FOLD US)

6
Analysis
Health CareUnited States
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
more
Company Event18 Feb 2026 13:00 • Upcoming
Add To Calendar
Company Event19 Nov 2025 00:30 • Latest
Company Event11 Nov 2025 03:45
Company Event04 Nov 2025 21:30
Company Event31 Jul 2025 20:30
x